Harrow, Inc. (HROW)
35.93
-1.36
(-3.65%)
USD |
NASDAQ |
Apr 10, 16:00
35.88
-0.05
(-0.14%)
After-Hours: 20:00
Harrow Market Cap : 1.338B for April 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Esperion Therapeutics, Inc. | 557.28M |
| Corcept Therapeutics, Inc. | 4.458B |
| Regeneron Pharmaceuticals, Inc. | 79.17B |
| Theravance Biopharma, Inc. | 841.91M |
| Rhythm Pharmaceuticals, Inc. | 5.763B |
Market Cap Related Metrics
| PS Ratio | 4.974 |
| Price to Book Value | 25.51 |
| Price to Free Cash Flow | 31.67 |
| Price | 35.93 |
| Earnings Yield | -0.46% |
| Operating PE Ratio | 34.76 |
| Normalized PE Ratio | 266.35 |